Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$10.0 million.

  • Beta Bionics' Free Cash Flow rose 1287.96% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.5 million, marking a year-over-year decrease of 6436.41%. This contributed to the annual value of -$51.7 million for FY2024, which is 5729.9% down from last year.
  • Per Beta Bionics' latest filing, its Free Cash Flow stood at -$10.0 million for Q3 2025, which was up 1287.96% from -$15.0 million recorded in Q2 2025.
  • Beta Bionics' Free Cash Flow's 5-year high stood at -$10.0 million during Q3 2025, with a 5-year trough of -$20.7 million in Q1 2025.